Literature DB >> 6181520

Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens.

A H Sehon.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6181520

Source DB:  PubMed          Journal:  Prog Allergy        ISSN: 0079-6034


× No keyword cloud information.
  8 in total

1.  Isotype-selective abrogation of established IgE responses.

Authors:  K T HayGlass; W Stefura
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus.

Authors:  E Nagy; I Berczi; A H Sehon
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehyde-polymerized allergen is independent of MHC haplotype and Igh allotype.

Authors:  K T Hayglass; W Stefura
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

4.  Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin.

Authors:  K T Hayglass; R S Gieni; W P Stefura
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

5.  Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice.

Authors:  M Haak-Frendscho; R Saban; R L Shields; P M Jardieu
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (Oligostick).

Authors:  T J Hall; J Brostoff
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

7.  Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo.

Authors:  M Haak-Frendscho; K Robbins; R Lyon; R Shields; J Hooley; M Schoenhoff; P Jardieu
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses.

Authors:  K T HayGlass; B P Stefura
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.